Trials / Not Yet Recruiting
Not Yet RecruitingNCT07137910
A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)
An Open-label, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B Previously Treated With Nucleos (t) Ide Analogues (NA)
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Ausper Biopharma Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study is an open-label, multicenter phase II clinical study to evaluate the efficacy and safety of AHB-137 injection in participants with CHB previously treated with NA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AHB-137 | AHB-137 will be injected |
Timeline
- Start date
- 2025-08-27
- Primary completion
- 2026-01-01
- Completion
- 2027-06-01
- First posted
- 2025-08-22
- Last updated
- 2025-08-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07137910. Inclusion in this directory is not an endorsement.